Search

• Type: Medical study ×
• Journal or magazine: Japanese Journal of Clinical Oncology ×
• Clear filters

1 result for “Reaction Department”

1. Medical study · Medical research · 2019

   Treatment status and safety of crizotinib in 2028 Japanese patients with ALK-positive NSCLC in clinical settings

   …included 2028 Japanese patients, and more than half of the patients (56.4%) were nonsmokers. The incidence of adverse drug reactions (ADRs) was 91.6%, and common ADRs (incidence ≥15%) were nausea (32.2%), diarrhea (24…